European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading

11:25 AM EDT, 08/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Monday morning, declining 0.12% to 1,470.85 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and semiconductor company Sequans Communications (SQNS), which rose 3.8% and 3.5% respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications operator Telefonica (TEF), which were up 1.4% and 1.1% respectively.

The decliners from continental Europe were led by medical device maker EDAP (EDAP) and biopharmaceutical company DBV Technologies (DBVT), which dropped 6.4% and 4.2% respectively. They were followed by furniture maker Natuzzi (NTZ) and internet browser company Opera (OPRA), which fell 3.9% and 3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 5.8% and 5.4% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were up 1.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and biotech firm Autolus Therapeutics (AUTL), which fell 5.1% and 3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and TC Biopharm (TCBP), which were down 2.6% and 1.5% respectively.